bluebird bio Inc. (NASDAQ: BLUE)
$1.42
+0.0950 ( +7.20% ) 5.2M
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
Market Data
Open
$1.42
Previous close
$1.32
Volume
5.2M
Market cap
$182.68M
Day range
$1.31 - $1.42
52 week range
$0.85 - $5.53
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Jul 11, 2024 |
4 | Insider transactions | 1 | Jul 03, 2024 |
3 | Insider transactions | 2 | Jun 24, 2024 |
4 | Insider transactions | 1 | Jun 24, 2024 |
8-k | 8K-related | 13 | Jun 24, 2024 |
3 | Insider transactions | 2 | Jun 13, 2024 |
4 | Insider transactions | 2 | Jun 04, 2024 |
8-k | 8K-related | 14 | May 29, 2024 |
nt | Quarterly Reports | 1 | May 15, 2024 |
8-k | 8K-related | 14 | May 09, 2024 |